These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11513007)

  • 21. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
    Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
    Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
    Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
    Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.
    Schneider JS
    PLoS One; 2018; 13(6):e0199189. PubMed ID: 29902255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?
    Kastner A; Hirsch EC; Lejeune O; Javoy-Agid F; Rascol O; Agid Y
    J Neurochem; 1992 Sep; 59(3):1080-9. PubMed ID: 1494900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.
    Zecca L; Stroppolo A; Gatti A; Tampellini D; Toscani M; Gallorini M; Giaveri G; Arosio P; Santambrogio P; Fariello RG; Karatekin E; Kleinman MH; Turro N; Hornykiewicz O; Zucca FA
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9843-8. PubMed ID: 15210960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies.
    Kitao S; Matsusue E; Fujii S; Miyoshi F; Kaminou T; Kato S; Ito H; Ogawa T
    Neuroradiology; 2013 Aug; 55(8):947-953. PubMed ID: 23673875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra.
    Aime S; Fasano M; Bergamasco B; Lopiano L; Valente G
    J Neurochem; 1994 Jan; 62(1):369-71. PubMed ID: 8263538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular chemical imaging of the developmental phases of human neuromelanin using synchrotron X-ray microspectroscopy.
    Bohic S; Murphy K; Paulus W; Cloetens P; Salomé M; Susini J; Double K
    Anal Chem; 2008 Dec; 80(24):9557-66. PubMed ID: 19007186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New face of neuromelanin.
    Double KL; Halliday GM
    J Neural Transm Suppl; 2006; (70):119-23. PubMed ID: 17017518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mössbauer spectroscopy and ELISA studies reveal differences between Parkinson's disease and control substantia nigra.
    Galazka-Friedman J; Bauminger ER; Koziorowski D; Friedman A
    Biochim Biophys Acta; 2004 Mar; 1688(2):130-6. PubMed ID: 14990343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease.
    Bergsland N; Zivadinov R; Schweser F; Hagemeier J; Lichter D; Guttuso T
    Mov Disord; 2019 Jul; 34(7):1006-1013. PubMed ID: 31180615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis.
    Jellinger K; Kienzl E; Rumpelmair G; Riederer P; Stachelberger H; Ben-Shachar D; Youdim MB
    J Neurochem; 1992 Sep; 59(3):1168-71. PubMed ID: 1494904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis.
    Plum S; Helling S; Theiss C; Leite REP; May C; Jacob-Filho W; Eisenacher M; Kuhlmann K; Meyer HE; Riederer P; Grinberg LT; Gerlach M; Marcus K
    J Proteomics; 2013 Dec; 94():202-206. PubMed ID: 23917253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.
    Zecca L; Tampellini D; Gerlach M; Riederer P; Fariello RG; Sulzer D
    Mol Pathol; 2001 Dec; 54(6):414-8. PubMed ID: 11724917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Label-Free Nanoimaging of Neuromelanin in the Brain by Soft X-ray Spectromicroscopy.
    Brooks J; Everett J; Lermyte F; Tjhin VT; Banerjee S; O'Connor PB; Morris CM; Sadler PJ; Telling ND; Collingwood JF
    Angew Chem Int Ed Engl; 2020 Jul; 59(29):11984-11991. PubMed ID: 32227670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients.
    Lopiano L; Chiesa M; Digilio G; Giraudo S; Bergamasco B; Torre E; Fasano M
    Biochim Biophys Acta; 2000 Mar; 1500(3):306-12. PubMed ID: 10699372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of neuromelanin on oxidative pathways within the human substantia nigra.
    Double KL; Ben-Shachar D; Youdim MB; Zecca L; Riederer P; Gerlach M
    Neurotoxicol Teratol; 2002; 24(5):621-8. PubMed ID: 12200193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson's disease and iron.
    Mochizuki H; Choong CJ; Baba K
    J Neural Transm (Vienna); 2020 Feb; 127(2):181-187. PubMed ID: 32025811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.